Novo Nordisk (NVON) Stock Statistics & Valuation Metrics
Total Valuation
Novo Nordisk has a market cap or net worth of MXN 3.31T. The enterprise value is MXN 227.20B.
- Market Cap
- MXN 3.31T
- Enterprise Value
- MXN 227.20B
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,390,128,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.74%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is 29.53%.
- Return on Equity (ROE)
- 0.53
- Return on Assets (ROA)
- 0.19
- Return on Invested Capital (ROIC)
- 29.53%
- Return on Capital Employed (ROCE)
- 0.39
- Revenue Per Employee
- 4.49M
- Profits Per Employee
- 1.49M
- Employee Count
- 68,794
- Asset Turnover
- 0.57
- Inventory Turnover
- 1.18
Valuation Ratios
The current PE Ratio of Novo Nordisk is 10.15. Novo Nordisk’s PEG ratio is 2.03.
- PE Ratio
- 10.15
- PS Ratio
- 3.56
- PB Ratio
- 5.33
- Price to FCF
- 23.99
- Price to Operating Cash Flow
- 8.86
- PEG Ratio
- 2.03
Income Statement
In the last 12 months, Novo Nordisk had revenue of 309.06B and earned 102.43B in profits. Earnings per share was 23.06.
- Revenue
- 309.06B
- Gross Profit
- 250.28B
- Operating Income
- 127.66B
- Pretax Income
- 130.54B
- Net Income
- 102.43B
- EBITDA
- 156.73B
- Earnings Per Share (EPS)
- 23.06
Cash Flow
In the last 12 months, operating cash flow was 133.01B and capital expenditures -84.09B, giving a free cash flow of 48.92B billion.
- Operating Cash Flow
- 133.01B
- Free Cash Flow
- 48.92B
- Free Cash Flow per Share
- 11.05
Dividends & Yields
Novo Nordisk pays an annual dividend of ―, resulting in a dividend yield of 4.10%
- Dividend Per Share
- ―
- Dividend Yield
- 4.10%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.17%
- Earnings Yield
- 9.88%
Stock Price Statistics
- Beta
- 0.07
- 52-Week Price Change
- -19.63%
- 50-Day Moving Average
- 730.19
- 200-Day Moving Average
- 755.73
- Relative Strength Index (RSI)
- 59.39
- Average Volume (3m)
- 6,468
Important Dates
Novo Nordisk upcoming earnings date is Nov 04, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 04, 2026
- Next Earnings Date
- Nov 04, 2026
- Ex-Dividend Date
- ―
Financial Position
Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 67.49%
- Current Ratio
- 0.80
- Quick Ratio
- 0.57
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 0.67
- Interest Coverage Ratio
- 30.34
Taxes
In the past 12 months, Novo Nordisk has paid 28.11B in taxes.
- Income Tax
- 28.11B
- Effective Tax Rate
- 0.22
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 7.15, with an EV/FCF ratio of 25.95.
- EV to Sales
- 3.85
- EV to EBITDA
- 7.15
- EV to Free Cash Flow
- 25.95
- EV to Operating Cash Flow
- 9.54
Balance Sheet
Novo Nordisk has MXN 44.98B in cash and marketable securities with MXN 140.13B in debt, giving a net cash position of -MXN 95.14B billion.
- Cash & Marketable Securities
- MXN 44.98B
- Total Debt
- MXN 140.13B
- Net Cash
- -MXN 95.14B
- Net Cash Per Share
- -MXN 28.07
- Tangible Book Value Per Share
- MXN 22.41
Margins
Gross margin is 80.65%, with operating margin of 43.13%, and net profit margin of 35.35%.
- Gross Margin
- 80.65%
- Operating Margin
- 43.13%
- Pretax Margin
- 45.15%
- Net Profit Margin
- 35.35%
- EBITDA Margin
- 53.89%
- EBIT Margin
- 45.65%
Analyst Forecast
The average price target for Novo Nordisk is MXN 793.78, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- MXN 793.78
- Price Target Upside
- 6.37% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 7
- Revenue Growth Forecast
- 2.82%
- EPS Growth Forecast
- 2.08%
Scores
- Smart Score
- 7
- AI Score
- ―